Pathophysiology and treatment of acute pancreatitis: New therapeutic targets - A ray of hope?

Basic and Clinical Pharmacology and Toxicology

Volumn 97, Issue 6, 2005, Pages 342-350

  Felderbauer, Peter ^a   Müller, Christophe ^a   Bulut, Kerem ^a   Belyaev, Orlin ^a   Schmitz, Frank ^a   Uhl, Waldemar ^a   Schmidt, Wolfgang E ^a  

^a ST JOSEF HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALOXISTATIN; ANGIOPEPTIN; ANTIBODY; ANTIOXIDANT; ASCORBIC ACID; CA 074ME; CALCIUM CHELATING AGENT; CATHEPSIN B INHIBITOR; CHEMOKINE; CHLOROQUINE; CURCUMIN; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; LEXIPAFANT; MACROPHAGE MIGRATION INHIBITION FACTOR; MACROPHAGE MIGRATION INHIBITION FACTOR ANTIBODY; OCTREOTIDE; PANCREAS ENZYME; PROTEIN INHIBITOR; PROTEINASE INHIBITOR; SELENIUM; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG; UNINDEXED DRUG; WORTMANNIN;

ACUTE PANCREATITIS; APACHE; AUTODIGESTION; CLINICAL TRIAL; DRUG EFFECT; ENZYMATIC DEGRADATION; ENZYME ACTIVATION; EXPERIMENTAL MODEL; HUMAN; INTENSIVE CARE; MULTIPLE ORGAN FAILURE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RANSON SCORE; SCORING SYSTEM; SHORT SURVEY; SUPERINFECTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALS; HUMANS; PANCREATITIS;

EID: 29744447921     PISSN: 17427835     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2005.pto_274.x     Document Type: Short Survey

References (59)

1. Abou-Assi, S., K. Craig & S. J. O'Keefe: Hypocaloric jejunal feeding is better than total parenteral nutrition in acute pancreatitis: results of a randomized comparative study. Amer. J. Gastroenterol. 2002, 97, 2255-2262.
2. Beger, H. G., R. Bittner, S. Block S. & M. Buchler: Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology 1986, 91, 433-438.
3. Berling, R., S. Genell S. & K. Ohlsson: High-dose intraperitoneal aprotinin treatment of acute severe pancreatitis: a double-blind randomized multi-center trial. J. Gastroenterol. 1994, 29, 479-485.
4. Bhagat, L., V. P. Singh, A. J. Hietaranta, S. Agrawal, M. L. Steer & A. K. Saluja: Heat shock protein 70 prevents secretagogue-induced cell injury in the pancreas by preventing intracellular trypsinogen activation. J. Clin. Invest. 2000, 106, 81-89.
5. Bradley, E. L., 3rd: Guiding the reluctant. A primer on guidelines in general and pancreatitis in particular. Pancreatology 2003, 3, 139-143.
6. British Society of Gastroenterology. United Kingdom guidelines for the management of acute pancreatitis. Gut 1998, 42 Suppl 2, S1-13.
7. Buchler, M., P. Malfertheiner, H. Friess, R. Isenmann, E. Vanek, H. Grimm, P. Schlegel, T. Friess & H. G. Beger: Human pancreatic tissue concentration of bactericidal antibiotics. Gastroenterology 1992, 103, 1902-1908.
8. Buchler, M., P. Malfertheiner, W. Uhl, J. Scholmerich, F. Stockmann, G. Adler, W. Gaus, K. Rolle & H. G. Beger: Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study Group. Gastroenterology 1993, 104, 1165-1170.
9. Cavallini, G., A. Tittobello, L. Frulloni, E. Masci, A. Mariana & V. Di Francesco: Gabexate for the prevention of pancreatic damage related to endoscopie retrograde cholangiopancreatography. Gabexate in digestive endoscopy-Italian Group. N. Engl. J. Med. 1996, 335, 919-923.
10. Chiari, H. Über die Selbstverdauung des menschlichen Pankreas. Z. Heilk. 1896, 17, 69-96.
11. Compton, S. J., J. A. Cairns, S. T. Holgate & A. F. Walls: The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release, and adhesion molecule expression: tryptase induces expression of mRNA for IL-1 beta and IL-8 and stimulates the selective release of IL-8 from human umbilical vein endothelial cells. J. Immunol. 1998, 161, 1939-1946.
12. de Beaux, A. C., K. R. Palmer & D. C. Carter: Factors influencing morbidity and mortality in acute pancreatitis; an analysis of 279 cases. Gut 1995, 37, 121-126.
13. Eibl, G., H. J. Buhr & T. Foitzik: Therapy of microcirculatory disorders in severe acute pancreatitis: what mediators should we block? Intensive Care Med. 2002, 28, 139-146.
14. Ethridge, R. T., R. A. Ehlers, M. R. Hellmich, S. Rajaraman & B. M. Evers: Acute pancreatitis results in induction of heat shock proteins 70 and 27 and heat shock factor-1. Pancreas 2000, 21, 248-256.
15. Foitzik, T., G. Eibl & H. J. Buhr: Therapy for microcirculatory disorders in severe acute pancreatitis: comparison of delayed therapy with ICAM-1 antibodies and a specific endothelin A receptor antagonist. J. Gastrointest. Surg. 2000a, 4, 240-246; discussion 247.
16. Foitzik, T., H. G. Hotz, G. Eibl & H. J. Buhr: Experimental models of acute pancreatitis: are they suitable for evaluating therapy? Int. J. Colorectal Dis. 2000b, 15, 127-135.
17. Foitzik, T., H. G. Hotz, B. Hotz, F. Wittig & H. J. Buhr: Selective inhibition of cyclooxygenase-2 (COX-2) reduces prostaglandin E2 production and attenuates systemic disease sequelae in experimental pancreatitis. Hepatogastroenterology 2003, 50, 1159-1162.
18. Frossard, J. L., A. Saluja, L. Bhagat, H. S. Lee, M. Bhatia, B. Hofbauer & M. L. Steer M. L.: The role of intercellular adhesion molecule 1 and neutrophils in acute pancreatitis and pancreatitis-associated lung injury. Gastroenterology 1999, 116, 694-701.
19. Gukovskaya, A. S., S. Hosseini, A. Satoh, J. H. Cheng, K. J. Nam, I. Gukovsky & S. J. Pandol: Ethanol differentially regulates NF-kappaB activation in pancreatic acinar cells through calcium and protein kinase C pathways. Amer. J. Physiol. Gastrointest. Liver Physiol. 2004, 286, G204-13.
20. Gukovsky I., J. H. Cheng, K. J. Nam, O. T. Lee, A. Lugea, L. Fischer, J. M. Penninger, S. J. Pandol & A. S. Gukovskaya: Phosphatidylinositide 3-kinase gamma regulates key pathologic responses to cholecystokinin in pancreatic acinar cells. Gastroenterology 2004, 126, 554-566.
21. Gukovsky, I., C. N. Reyes, E. C. Vaquero, A. S. Gukovskaya & S. J. Pandol: Curcumin ameliorates ethanol and nonethanol experimental pancreatitis. Amer. J. Physiol. Gastrointest. Liver Physiol. 2003, 284, G85-95.
22. Isenmann, R., M. Runzi, M. Kron, S. Kahl, D. Kraus, N. Jung, L. Maier, P. Malfertheiner, H. Goebell & H. G. Beger: Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial. Gastroenterology 2004, 126, 997-1004.
23. Johnson, C. D., A. N. Kingsnorth, C. W. Imrie, M. J. McMahon, J. P. Neoptolemos, C. McKay, S, K. Toh, P. Skaife, P. C. Leeder, P. Wilson, M. Larvin & L. D. Curtis: Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. Gut 2001, 48, 62-69.
24. Katz, M., R. Carangelo, L. J. Miller & F. Gorelick: Effect of ethanol on cholecystokinin-stimulated zymogen conversion in pancreatic acinar cells. Amer. J. Physiol. 1996, 270, G171-175.
25. Kaufmann, P., G. P. Tilz, K. H. Smolle, U. Demel & G. J. Krejs: Increased plasma concentrations of circulating intercellular adhesion molecule-1 (cICAM-1) in patients with necrotizing pancreatitis. Immunobiology 1996, 195, 209-219.
26. Kruger, B., E. Albrecht & M. M. Lerch: The Role of Intracellular Calcium Signaling in Premature Protease Activation and the Onset of Pancreatitis. Amer. J. Pathol. 2000, 157, 43-50.
27. Kubisch, C., M. J. Dimagno, A. B. Tietz, M. J. Welsh, S. A. Ernst, B. Brandt-Nedelev, J. Diebold, A. C. Wagner, G. Goke, J. A. Williams & C. Schafer: Overexpression of heat shock protein Hsp27 protects against cerulein-induced pancreatitis. Gastroenterology 2004, 127, 275-286.
28. Makhija, R. & A. N. Kingsnorth: Cytokine storm in acute pancreatitis. J. Hepatobiliary Pancreat. Surg. 2002, 9: 401-410.
29. Mayumi, T., H. Ura, S. Arata, N. Kitamura, I. Kiriyama, K. Shibuya, M. Sekimoto, N. Nago, M. Hirota, M. Yoshida, Y, Ito, K. Hirata & T. Takada: Evidence-based clinical practice guidelines for acute pancreatitis: proposals. J. Hepatobiliary Pancreat. Surg. 2002, 9, 413-422.
30. Mitchell, R. M., M. F. Byrne & J. Baillie: Pancreatitis. Lancet 2003, 361, 1447-1455.
31. Mooren, F. C., V. Hlouschek, T. Finkes, S. Turi, I. A. Weber, J. Singh, W. Domschke, J. Schnekenburger, B. Kruger & M. M. Lerch: Early changes in pancreatic acinar cell calcium signaling after pancreatic duct obstruction. J. Biol. Chem. 2003, 278, 9361-9369.
32. Murray, B., R. Carter, C. Imrie, S. Evans & C. O'Suilleabhain: Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology 2003, 124, 1787-1791.
33. Nguyen, T. D.: Proteinase activated receptor 2: a protean effector comes of age. Gastroenterology 2004, 126, 1907-1909 (review).
34. Niederau, C., M. Niederau, R. Luthen, G. Strohmeyer, L. D. Ferrell & J. H. Grendell: Pancreatic exocrine secretion in acute experimental pancreatitis. Gastroenterology 1990, 99, 1120-1127.
35. Oruc, N., A. O. Ozutemiz, V. Yukselen, D. Nart, H. A. Celik, G. Yuce & Y. Batur: Infliximab: a new therapeutic agent in acute pancreatitis? Pancreas 2004, 28, e1-8.
36. Owyang, C. & C. D. Logsdon: New insights into neurohormonal regulation of pancreatic secretion. Gastroenterology 2004, 127, 957-969.
37. Pandol, S. J., I. Gukovsky, A. Satoh, A. Lugea & A. S. Gukovskaya: Animal and in vitro models of alcoholic pancreatitis: role of cholecystokinin. Pancreas 2003, 27, 297-300.
38. Pederzoli, P., G. Cavallini, M. Falconi & C. Bassi: Gabexate mesilate vs aprotinin in human acute pancreatitis (GA.ME.P.A.). A prospective, randomized, double-blind multicenter study. Int. J. Pancreatol. 1993, 14, 117-124.
39. Sakai Y., A. Masamune, A. Satoh, J. Nishihira, T. Yamagiwa & T. Shimosegawa: Macrophage migration inhibitory factor is a critical mediator of severe acute pancreatitis. Gastroenterology 2003, 124, 725-736.
40. Saluja, A. K. & L. Bhagat: Pancreatitis and associated lung injury: when MIF miffs. Gastroenterology 2003, 124, 844-847.
41. Saluja, A. K., E. A. Donovan, K. Yamanaka, Y. Yamaguchi, B. Hofbauer & M. L. Steer: Cerulein-induced in vitro activation of trypsinogen in rat pancreatic acini is mediated by cathepsin B. Gastroenterology 1997a, 113, 304-310.
42. Saluja, A. K., L. Lu, Y. Yamaguchi, B. Hofbauer, M. Runzi, R. Dawra, M. Bhatia & M. L. Steer: A Cholecystokinin-releasing Factor Mediates Ethanol-induced Stimulation of Rat Pancreatic Secretion. J. Clin. Invest. 1997b, 99, 506-512.
43. Sandoval, D., A. Gukovskaya, P. Reavey, S. Gukovsky, A. Sisk, P. Braquet, S. J. Pandol & S. Poucell-Hatton: The role of neutrophils and platelet-activating factor in mediating experimental pancreatitis. Gastroenterology 1996, 111, 1081-1091.
44. Sarr, M. G.: IAP guidelines in acute pancreatitis. Dig. Surg. 2003, 20, 1-3.
45. Seyama, Y., T. Otani, A. Matsukura & M. Makuuchi M.: The pH modulator chloroquine blocks trypsinogen activation peptide generation in cerulein-induced pancreatitis. Pancreas 2003, 26, 15-7.
46. Singh, V. P., A. K. Saluja, L. Bhagat, G. J. van Acker, A. M. Song, S. P. Soltoff, L. C. Cantley & M. L. Steer: Phosphatidylinositol 3-kinase-dependent activation of trypsinogen modulates the severity of acute pancreatitis. J. Clin. Invest, 2001, 108, 1387-1395.
47. Slogoff, M. I., R. T. Ethridge, S. Rajaraman & B. M. Evers: COX-2 inhibition results in alterations in nuclear factor (NF)-kappaB activation but not cytokine production in acute pancreatitis. J. Gastrointest Surg. 2004, 8, 511-519.
48. Song, A. M., L. Bhagat, V. P. Singh, G. G. Van Acker, M. L. Steer & A. K. Saluja: Inhibition of cyclooxygenase-2 ameliorates the severity of pancreatitis and associated lung injury. Amer. J. Physiol. Gastrointest. Liver Physiol. 2004, 283, G1166-1174.
49. Steinberg, W. M. & S. E. Schlesselman: Treatment of acute pancreatitis. Comparison of animal and human studies. Gastroenterology 1987, 93, 1420-1427.
50. Steinberg, W. & S. Tenner: Acute Pancreatitis. N. Engl. J. Med. 1994, 330, 1198-1210.
51. Sutton, R., D. Criddle, M. G. Raraty, A. Tepikin, J. P. Neoptolemos & O. H. Petersen: Signal transduction, calcium and acute pancreatitis. Pancreatology 2003, 3, 497-505.
52. The Society for Surgery of the Alimentary Tract Patient Care Committee. Treatment of acute pancreatitis. J. Gastrointest. Surg. 1998, 2, 487-488.
53. Uhl, W., M. W. Buchler, P. Malfertheiner, H. G. Beger, G. Adler & W. Gaus: A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis. Gut 1999, 45, 97-104.
54. Uhl, W., A. Warshaw, C. Imrie, C. Bassi, C. J. McKay, P. G. Lankisch, R. Carter, E. Di Magno, P. A. Banks, D. C. Whitcomb, C. Dervenis, C. D. Ulrich, K. Satake, P. Ghaneh, W. Hartwig, J. Werner, G. McEntee, J. P. Neoptolemos & M. W. Buchler: IAP guidelines for the surgical management of acute pancreatitis. Pancreatology 2002, 2, 565-573.
55. van Acker, G. J. D., A. K. Saluja, L. Bhagat, V. P. Singh, A. M. Song & M. L. Steer: Cathepsin B inhibition prevents trypsinogen activation and reduces pancreatitis severity. Amer. J. Physiol. Gastrointest. Liver Physiol. 2002, 283, G794-800.
56. Virlos, I. T., J. Mason, D. Schofield, R. F. McCloy, J. M. Eddleston & A. K. Siriwardena: Intravenous n-acetylcysteine, ascorbic acid and selenium-based anti-oxidant therapy in severe acute pancreatitis. Scand. J. Gastroenterol. 2003, 38, 1262-1267.
57. Wang, X., Z. Sun, A. Börjesson & R. Andersson: Inhibition of platelet-activating factor, intercellular adhesion molecule 1 and platelet endothelial cell adhesion molecule 1 reduces experimental pancreatitis- associated gut endothelial barrier dysfunction. Brit. J. Surg. 1999, 86, 411-416.
58. Ward, J., R. Sutton, S. Jenkins & O. Petersen: Progressive disruption of acinar cell calcium signaling is an early feature of cerulein-induced pancreatitis in mice. Gastroenterology 1996, 111, 481-491.
59. Werner, J., M. Laposata, C. Fernandez-del Castillo, M. Saghir, R. V. Iozzo, K. B. Lewandrowski & A. L. Warshaw: Pancreatic injury in rats induced by fatty acid ethyl ester, a nonoxidative metabolite of alcohol. Gastroenterology 1997, 113, 286-294.